Evidence map›Paper›PMID 39707874›Full record

ArticleAllergy2025

Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma.

Stephane Esnault, Ksenija Bernau, Heather L Floerke, Arnaud Dendooven, Emeline Delaunay, Kimberly A Dill-McFarland, Matthew C Altman, William W Busse, Melissa A Rosenkranz, Matthew C Tattersall and 13 more

Abstract readLetter
In one paragraph

Article in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Identification of the Cytokines, Growth Factors and Their Receptors Expressed by Human Blood Eosinophils: A Transcriptomics Approach.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Stephane EsnaultUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.ORCID https://orcid.org/0000-0001-7238-8671
Ksenija BernauDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Heather L FloerkeDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Arnaud DendoovenUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Emeline DelaunayUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Kimberly A Dill-McFarlandDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Matthew C AltmanDivision of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
William W BusseDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0003-2591-4696
Melissa A RosenkranzCenter for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Matthew C TattersallDivision of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Mats W JohanssonDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0001-5699-978X
Julien LabreucheHealth Statistics, SEED: Statistique, évaluation, économique, Data-Management Maison Régionale de la Recherche Clinique University Hospital of Lille, Lille, France.
Delphine BeuryUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, US 41-UAR 2014-PLBS, Lille, France.
Shéhérazade SebdaUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, US 41-UAR 2014-PLBS, Lille, France.
Frédéric DezoteuxUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.ORCID https://orcid.org/0000-0001-8930-1042
Baptiste SegardUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Geoffrey MortuaireUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Delphine Staumont-SalléUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Thomas StoupUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Cécile ChenivesseCEREO, National Reference Center for Hypereosinophilic Syndromes, Suresnes, France.
Nathan SandboDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Nizar N JarjourDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Guillaume LefèvreUniv. Lille, INSERM, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
Thr Role of Pin1 in AirwayP01HL088594 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI JARJOUR, NIZAR N · 2008 to 2017
$21.0M
Asthmatic Inflammation and Neurocircuitry ActivationR01HL123284 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BUSSE, WILLIAM W. · 2016 to 2019
$2.9M
Elucidating tensin1-associated signals that promote fibronectin matrix assembly and lung fibrosisR01HL146402 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI SANDBO, NATHAN K · 2019 to 2023
$1.7M
Neural mechanisms by which chronic stress regulates inflammation in asthmaK01AT006202 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI ROSENKRANZ, MELISSA A · 2010 to 2014
$471k
Centre hospitalier régional universitaire de LilleInstitut National de la Santé et de la Recherche MédicaleNCATS NIH HHS UL1 TR002373NCCIH NIH HHS K01 AT006202NCRR NIH HHS UL1 RR025011NHLBI NIH HHS P01 HL088594NHLBI NIH HHS R01 HL123284NHLBI NIH HHS R01 HL146402NIH HHSPulmonary Fibrosis FoundationUniversity of Wisconsin-MadisonU.S. Department of Defense
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allergyasthmabronchoalveolar lavageCRSwNPcytolysisdegranulationeosinophilsOncostatin Msevere asthma

Identifiers

PMID39707874
PMCPMC11969300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.